The purpose of this study is to evaluate the activities of the I.G. Farben laboratory at the former "Heil- und Pflegeanstalt" Günzburg. This laboratory was established to test the newly developed epilepsy drug "Citrullamon" and its derivatives. Specifically, the type and manner of the various experiments were examined to determine whether the suspicions of unethical human experimentation could be identified. The commercial and medical activities between I.G. Farben and the Heil- und Pflegeanstalt, including the specific roles of the senior physician Wilhelm Leinisch and the I.G. Farben chemist Arno Grosse, are reviewed.